How Cancer Victims Can Double Survival
Study: Smokers With Early Lung Cancer Could Double Survival Chances If They Quit
Read more on CBS News
How Cancer Victims Can Double Survival
Study: Smokers With Early Lung Cancer Could Double Survival Chances If They Quit
Read more on CBS News
Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)–typically used in combination with chemotherapy. However, a new study by researchers at Fox Chase Cancer Center reports that it may be safe to treat these patients with both Trastuzumab and adjuvant radiation therapy.
The study will be presented at the annual meeting of the American Society for Radiation Oncology (ASTRO).
» Read more: Terramed Alliance News Safe To Treat HER2-positive Breast Cancer
Cancer Society Says U.S. Report Failed to Prove Health Risks
President’s Cancer Panel called for more public awareness of harm from common chemicals.
Read more on HealthCentral